We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Drugmakers Should Review Studies Conducted by MDS Pharma
FDA: Drugmakers Should Review Studies Conducted by MDS Pharma
January 12, 2007
The FDA is sending more than 1,100 letters to pharmaceutical companies advising them to reevaluate pharmacokinetic studies conducted by contract company MDS Pharma Services because the results may be invalid.